Latest Kensey Nash Corporation Stories
EXTON, Pa., May 3, 2012 /PRNewswire/ -- Kensey Nash Corporation (NASDAQ: KNSY), a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its third fiscal quarter ended March 31, 2012. As reported in a separate press release issued today, the Company has entered into a definitive agreement with Royal DSM ("DSM") (NYSE Euronext: DSM KON), pursuant to which the Company would be acquired through a cash...
EXTON, Pa., May 3, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY), today announced that it has entered into a definitive agreement with Royal DSM (DSM) (NYSE Euronext: DSM KON), under which DSM has agreed to acquire all of the common stock of Kensey Nash through a cash tender offer, followed by a merger with a subsidiary of DSM, for $38.50 per share in cash. "We are very pleased to have entered into the merger agreement with DSM, as the transaction will deliver...
EXTON, Pa., April 24, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its third quarter ended March 31, 2012 at 7:00 A.M. Eastern Time on Thursday, May 3, 2012. Joe Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings results on Thursday, May 3, 2012 at 9:00 A.M. Eastern Time. To participate in the teleconference call, please dial 612-332-0523. Individuals interested in...
EXTON, Pa., April 24, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY), a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced the achievement of several milestones for its Meso BioMatrix(TM) surgical mesh including the first clinical implant of the product. The Meso BioMatrix(TM) product is indicated for use in the United States for implantation to reinforce soft tissue where...
EXTON, Pa., March 16, 2012 /PRNewswire/ -- Kensey Nash Corporation (NASDAQ: KNSY) today announced that the Company has entered into a settlement agreement with St. Jude Medical which resolves all disputes between the two companies relating to the Angio-Seal vascular closure device licenses, as well as other related claims. As part of the settlement agreement, the companies also agreed to extend their collagen supply agreement through 2017 and expand the minimums to be provided over...
EXTON, Pa., March 13, 2012 /PRNewswire/ -- The board of directors of Kensey Nash Corporation (Nasdaq: KNSY) announced today that the board has declared a cash dividend of $0.25 per share of the Company's common stock, payable to stockholders of record on April 30, 2012. The dividend will be paid on May 31, 2012. A total of approximately $2.2 million will be paid on the Company's 8.7 million outstanding shares of common stock. This declaration is the second consecutive quarterly...
EXTON, Pa., March 12, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Sidoti & Company Sixteenth Annual New York Institutional Investor Forum on Monday, March 19, 2012 at The Grand Hyatt Hotel in New York. Joseph W. Kaufmann, Kensey Nash's Chief Executive Officer, will deliver the Company's presentation, beginning approximately at 10:40 a.m. (ET). The presentation materials will be available on the company's website (www.kenseynash.com)...
EXTON, Pa., Feb. 3, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Canaccord Genuity Musculoskeletal Conference held on Tuesday, February 7, 2012 at Parc 55 in San Francisco, California. Joseph W. Kaufmann, Kensey Nash's President and CEO, will deliver the Company's presentation, beginning approximately at 10:40 a.m. (PT). The presentation materials will be available on the company's website (www.kenseynash.com) beginning at 10:40 a.m....
EXTON, Pa., Feb. 2, 2012 /PRNewswire/ -- Kensey Nash Corporation (NASDAQ: KNSY), a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its second fiscal quarter ended December 31, 2011. Second Quarter Snapshot and Recent Developments Adjusted diluted earnings per share* of $0.51 (which excludes Norian inventory step-up amortization; see discussion below), a 34% increase from prior year diluted earnings...
EXTON, Pa., Jan. 17, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it will release its earnings results for its second quarter ended December 31, 2011 at 7:00 A.M. Eastern Time on Thursday, February 2, 2012. Joe Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings results on Thursday, February 2, 2012 at 9:00 A.M. Eastern Time. To participate in the teleconference call, please dial 703-639-1429....
